12478 results for

Refine Your Search

The National Coalition for LGBTQ Health

To improve the health and of lesbian, gay, bisexual, and transgender individuals through federal and local advocacy, education, and research. The Coa…

Cleveland Clinic 4th Angel Mentoring Program

To provide personalized peer support empowering those affected by cancer and its treatmentMatches individuals impacted by cancer for support with a t…

Inheritance of Hope

To inspire hope in young families facing the loss of a parentOffers online weekly support groups (Hope@Home) for all ages, whether living with illness…

Nikki

Nikki

I was diagnosed with Hodgkin lymphoma (HL) about a month and a half ago at the age of . This was my first year out of nursing school; I had just lande…

Dare 2 Dream

A Decentralized Randomized High-Fiber Dietary Trial to Improve Outcomes in Newly Diagnosed Myeloma

We will conduct a decentralized randomized controlled trial of a dietary intervention among patients with multiple myeloma undergoing induction chem…

Urvi Shah

Urvi Shah

Dr. Urvi Shah is an Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center. She is board certified in Internal Medicine,…

Mechanisms of Inducing differentiation in CBFA2T3-GLIS2 positive AML

AMKL is a rare leukemia that largely affects infants and toddlers. Of the various subtypes of this disease, CBAF2T3-GLIS2 positive AMKL has proven par…

Paola Aguilar Neuville

Paola Aguilar Neuville

Paola Aguilar Neuville is a 3rd year medical student at Indiana University School of Medicine. As a Latina woman from a region where treatable cancers…

Cellular and genetic drivers of Cutaneous γδ T-cell lymphomas (PCGDTL)

Primary cutaneous γδ lymphoma (PCGDTL) is a rare type of lymphoma caused by the rare types of called γδ (most T cells in our body in αβ ). The dise…

Jennifer Amengual

Jennifer Amengual

Jennifer Amengual, MD is an Associate Professor of Medicine at Columbia University in the Division of Hematology and Oncology. As a , her research goa…

Defining ctDNA monitoring and immune modulation in a novel, risk stratified clinical trial for PTLD

Posttransplant lymphoproliferative disorders (PTLD) are a group of lymphomas that arise during immunosuppression following organ transplantation and a…

BioInvent announces promising initial efficacy data from triple combination arm of BI-1206, rituximab and Calquence for the treatment of non-Hodgkin's lymphoma

BioInvent announces promising initial efficacy data from triple combination arm of BI-1206, rituximab and Calquence for the treatment of non-Hodgkin's lymphoma

Lund, Sweden – January , – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and developm…

Education Resources

Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types

Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types

The FDA approval will benefit children and adults with acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). Rye Brook, N.Y., January , …

Education Resources

In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients

In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients

January , – This week, LLS has heard great concern from patients, caregivers, volunteers, healthcare professionals, researchers, community organizati…

News Release

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

SAN DIEGO, Feb. , - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from , the Phase trial of ziftomenib, a …

News Release

From office to Andes: Blood Cancer United CFO takes the mission to new heights

From office to Andes: Blood Cancer United CFO takes the mission to new heights

JR Miller at Palomani Pass, the highest point on the Ausangate trek in Peru at , meters (, feet)After years of service to The Leukemia & Lymphoma Soc…

Nevaeh

Nevaeh

Nevaeh was diagnosed with acute myeloid leukemia (AML+MLLr)+CNS chloromas on February , , at months old. Nevaeh first showed symptoms of high fevers,…

Dare 2 Dream

AnnaKate

AnnaKate

In my junior year of college, I felt so sick that I would sleep through online classes, throwing up every couple of days. I thought I was just stresse…

Dare 2 Dream

Thank You

Thank You

On behalf of people with blood cancer, thank you for your gift to The Leukemia & Lymphoma Society (LLS).To view your donation details, please log in t…

Gary

Gary

My stepdad Gary passed away from leukemia on October , . He began feeling ill in September ― lightheaded and dizzy. He took himself to the hospital, …

Nicolasa

Nicolasa

The first time I heard of Team In Training (TNT) and raising money for The Leukemia & Lymphoma Society (LLS) was when my friend and I wanted to run th…

FAQs: Proposed federal spending cuts and blood cancer research and care

FAQs: Proposed federal spending cuts and blood cancer research and care

The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…

News Release

Leukemia vs. lymphoma: What you need to know

Leukemia vs. lymphoma: What you need to know

Table of contentsLeukemia vs. Lymphoma: What You Need to KnowWhat Is Leukemia?Organs Affected by LeukemiaWhat Is Lymphoma?Organs Affected by LymphomaD…

Lymphoma diagnosis, survival rate by age, prognosis, and treatment

Lymphoma diagnosis, survival rate by age, prognosis, and treatment

Table of contents:What is Hodgkin lymphoma? Organs affected by Hodgkin lymphomaHodgkin lymphoma symptoms and early signsWhat is lymphoma?Organs affec…

Myeloma Awareness Month: Aiming for more

Myeloma Awareness Month: Aiming for more

MORE. Not a word you’d expect to associate with myeloma, is it? Actually, it may the perfect word for looking beyond this rare, incurable, AND treatab…